164 related articles for article (PubMed ID: 35614169)
1. Integrating Routine Screening for Opioid Use Disorder into Primary Care Settings: Experiences from a National Cohort of Clinics.
Austin EJ; Briggs ES; Ferro L; Barry P; Heald A; Curran GM; Saxon AJ; Fortney J; Ratzliff AD; Williams EC
J Gen Intern Med; 2023 Feb; 38(2):332-340. PubMed ID: 35614169
[TBL] [Abstract][Full Text] [Related]
2. Integrating Opioid Use Disorder Treatment Into Primary Care Settings.
Austin EJ; Chen J; Briggs ES; Ferro L; Barry P; Heald A; Merrill JO; Curran GM; Saxon AJ; Fortney JC; Ratzliff AD; Williams EC
JAMA Netw Open; 2023 Aug; 6(8):e2328627. PubMed ID: 37566414
[TBL] [Abstract][Full Text] [Related]
3. PRimary Care Opioid Use Disorders treatment (PROUD) trial protocol: a pragmatic, cluster-randomized implementation trial in primary care for opioid use disorder treatment.
Campbell CI; Saxon AJ; Boudreau DM; Wartko PD; Bobb JF; Lee AK; Matthews AG; McCormack J; Liu DS; Addis M; Altschuler A; Samet JH; LaBelle CT; Arnsten J; Caldeiro RM; Borst DT; Stotts AL; Braciszewski JM; Szapocznik J; Bart G; Schwartz RP; McNeely J; Liebschutz JM; Tsui JI; Merrill JO; Glass JE; Lapham GT; Murphy SM; Weinstein ZM; Yarborough BJH; Bradley KA
Addict Sci Clin Pract; 2021 Jan; 16(1):9. PubMed ID: 33517894
[TBL] [Abstract][Full Text] [Related]
4. Advancing pharmacological treatments for opioid use disorder (ADaPT-OUD): protocol for testing a novel strategy to improve implementation of medication-assisted treatment for veterans with opioid use disorders in low-performing facilities.
Hagedorn H; Kenny M; Gordon AJ; Ackland PE; Noorbaloochi S; Yu W; Harris AHS
Addict Sci Clin Pract; 2018 Dec; 13(1):25. PubMed ID: 30545409
[TBL] [Abstract][Full Text] [Related]
5. Stakeholder perspectives on a telemedicine referral and coordination model to expand medication treatment for opioid use disorder in rural primary care clinics.
Ober AJ; Dopp AR; Clingan SE; Curtis ME; Lin C; Calhoun S; Larkins S; Black M; Hanano M; Osterhage KP; Baldwin LM; Saxon AJ; Hichborn EG; Marsch LA; Mooney LJ; Hser YI
J Subst Use Addict Treat; 2024 Jan; 156():209194. PubMed ID: 37863356
[TBL] [Abstract][Full Text] [Related]
6. Early impacts of a multi-faceted implementation strategy to increase use of medication treatments for opioid use disorder in the Veterans Health Administration.
Gustavson AM; Wisdom JP; Kenny ME; Salameh HA; Ackland PE; Clothier B; Noorbaloochi S; Gordon AJ; Hagedorn HJ
Implement Sci Commun; 2021 Feb; 2(1):20. PubMed ID: 33588952
[TBL] [Abstract][Full Text] [Related]
7. Contextual barriers and enablers to establishing an addiction-focused consultation team for hospitalized adults with opioid use disorder.
Evans SK; Ober AJ; Korn AR; Peltz A; Friedmann PD; Page K; Murray-Krezan C; Huerta S; Ryzewicz SJ; Tarhuni L; Nuckols TK; E Watkins K; Danovitch I
Addict Sci Clin Pract; 2024 Apr; 19(1):31. PubMed ID: 38671482
[TBL] [Abstract][Full Text] [Related]
8. Implementation of medication for opioid use disorder treatment in Indian health clinics in California: A qualitative evaluation.
Soto C; Miller K; Moerner L; Nguyen V; Ramos GG
J Subst Use Addict Treat; 2023 Dec; 155():209115. PubMed ID: 37399928
[TBL] [Abstract][Full Text] [Related]
9. Fluctuations in barriers to medication treatment for opioid use disorder prescribing over the course of a one-year external facilitation intervention.
Gustavson AM; Kenny ME; Wisdom JP; Salameh HA; Ackland PE; Gordon AJ; Hagedorn HJ
Addict Sci Clin Pract; 2021 Aug; 16(1):51. PubMed ID: 34362445
[TBL] [Abstract][Full Text] [Related]
10. Perspectives of clinical stakeholders and patients from four VA liver clinics to tailor practice facilitation for implementing evidence-based alcohol-related care.
Soyer EM; Frost MC; Fletcher OV; Ioannou GN; Tsui JI; Edelman EJ; Weiner BJ; Bachrach RL; Chen JA; Williams EC
Addict Sci Clin Pract; 2024 Jan; 19(1):3. PubMed ID: 38200496
[TBL] [Abstract][Full Text] [Related]
11. Barriers and facilitators to implementing medications for opioid use disorder and naloxone distribution in Veterans Affairs emergency departments.
Sasson C; Dieujuste N; Klocko R; Basrai Z; Celedon M; Hsiao J; Himstreet J; Hoffman J; Pfaff C; Malmstrom R; Smith J; Holstein A; Johnson-Koenke R
Acad Emerg Med; 2023 Apr; 30(4):289-298. PubMed ID: 36757683
[TBL] [Abstract][Full Text] [Related]
12. A randomized matched-pairs study of feasibility, acceptability, and effectiveness of systems consultation: a novel implementation strategy for adopting clinical guidelines for Opioid prescribing in primary care.
Quanbeck A; Brown RT; Zgierska AE; Jacobson N; Robinson JM; Johnson RA; Deyo BM; Madden L; Tuan WJ; Alagoz E
Implement Sci; 2018 Jan; 13(1):21. PubMed ID: 29370813
[TBL] [Abstract][Full Text] [Related]
13. Co-occurring substance use disorders among patients with opioid use disorder in rural primary care clinics.
Zhu Y; Baldwin LM; Mooney LJ; Saxon AJ; Kan E; Hser YI
J Subst Use Addict Treat; 2024 Mar; 158():209269. PubMed ID: 38097045
[TBL] [Abstract][Full Text] [Related]
14. Primary Care Providers' Experiences Treating Opioid Use Disorder Using Telehealth in the Height of the COVID-19 Pandemic.
Marshall SA; Siebenmorgen LE; Youngen K; Borders T; Zaller N
J Prim Care Community Health; 2024; 15():21501319241246359. PubMed ID: 38600789
[TBL] [Abstract][Full Text] [Related]
15. Increasing access to quality care for pregnant and postpartum people with opioid use disorder: Coordination of services, provider awareness and training, extended postpartum coverage, and perinatal quality collaboratives.
Ellick KL; Kroelinger CD; Chang K; McGown M; McReynolds M; Velonis AJ; Bronson E; Riehle-Colarusso T; Pliska E; Akbarali S; Mueller T; Dronamraju R; Cox S; Barfield WD
J Subst Use Addict Treat; 2024 Jan; 156():209208. PubMed ID: 37939904
[TBL] [Abstract][Full Text] [Related]
16. Use of Telehealth for Opioid Use Disorder Treatment in Safety Net Primary Care Settings: A Mixed-Methods Study.
Bailey SR; Wyte-Lake T; Lucas JA; Williams S; Cantone RE; Garvey BT; Hallock-Koppelman L; Angier H; Cohen DJ
Subst Use Misuse; 2023; 58(9):1143-1151. PubMed ID: 37170596
[No Abstract] [Full Text] [Related]
17. Increasing Access to Medications for Opioid Use Disorder and Complementary and Integrative Health Services in Primary Care.
Chang ET; Oberman RS; Cohen AN; Taylor SL; Gumm E; Mardian AS; Toy S; Revote A; Lewkowitz B; Yano EM
J Gen Intern Med; 2020 Dec; 35(Suppl 3):918-926. PubMed ID: 33145686
[TBL] [Abstract][Full Text] [Related]
18. Increasing buprenorphine access for veterans with opioid use disorder in rural clinics using telemedicine.
Brunet N; Moore DT; Lendvai Wischik D; Mattocks KM; Rosen MI
Subst Abus; 2022; 43(1):39-46. PubMed ID: 32078492
[No Abstract] [Full Text] [Related]
19. Is telemedicine the answer to rural expansion of medication treatment for opioid use disorder? Early experiences in the feasibility study phase of a National Drug Abuse Treatment Clinical Trials Network Trial.
Hser YI; Ober AJ; Dopp AR; Lin C; Osterhage KP; Clingan SE; Mooney LJ; Curtis ME; Marsch LA; McLeman B; Hichborn E; Lester LS; Baldwin LM; Liu Y; Jacobs P; Saxon AJ
Addict Sci Clin Pract; 2021 Apr; 16(1):24. PubMed ID: 33879260
[TBL] [Abstract][Full Text] [Related]
20. Stigma towards opioid use disorder in primary care remain a barrier to integrating software-based measurement based care.
Dela Cruz AM; Karns-Wright T; Kahalnik F; Walker R; Lanham HJ; Potter JS; Trivedi MH
BMC Psychiatry; 2023 Oct; 23(1):776. PubMed ID: 37875835
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
